Could Merck (MRK) Join the Bidding for Medivation (MDVN)?

Go back to Could Merck (MRK) Join the Bidding for Medivation (MDVN)?

Medivation (MDVN) PT Raised to $76 at Maxim Group with Shares 'In Play'

May 5, 2016 3:27 PM EDT

Maxim Group analyst Jason Kolbert raised his price target on Buy-rated Medivation (NASDAQ: MDVN) to $76.00 (from $47.00) with the company 'in play'.

Kolbert highlighted:

Medivation is returning to new highs as suitors line up to make acquisition bids. In this... More

Amgen (AMGN) said to be evaluating Medivation (MDVN) bid - Bloomberg

May 5, 2016 9:49 AM EDT

Amgen (NASDAQ: AMGN) said to be evaluating Medivation (NASDAQ: MDVN) bid - Bloomberg

... More

UPDATE: Amgen (AMGN) Said Weighing Medivation (MDVN) Bid - Bloomberg

May 5, 2016 9:48 AM EDT

(Updated - May 5, 2016 9:56 AM EDT)

Amgen (Nasdaq: AMGN) is considering a bid for Medivation (Nasdaq: MDVN), according to Bloomberg, citing people with knowledge of the matter. Amgen is speaking with advisers as it evaluates... More

Sanofi (SNY) Sends New Letter to Medivation (MDVN) Board; Says Shareholders Support Deal

May 5, 2016 8:27 AM EDT

Sanofi today announced that it has sent a letter to Medivation, Inc.'s (NASDAQ: MDVN) Board of Directors. The full text of the letter reads as follows:

Board of Directors
Medivation, Inc.
525 Market Street, 36th floor
San Francisco, CA 94105

Paris, May 4th, 2016

Dear Members of the Board of... More